Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGLE: Lysis vs conservative treatment in central retinal artery occlusion
DRKS00000088Phase 3Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Feb 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of tissue-plasminogen activator in central retinal artery occlusion (CRAO), sponsored by Universitätsklinikum Freiburg. Started Feb 2009; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
central retinal artery occlusion (CRAO)
Beyond the preview
Go deeper on DRKS00000088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000088.